RhumbLine Advisers’s Innate Pharma IPHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822 | Sell |
470
-205
| -30% | -$359 | ﹤0.01% | 4051 |
|
|
2025
Q1 | $1.2K | Hold |
675
| – | – | ﹤0.01% | 4019 |
|
|
2024
Q4 | $1.25K | Buy |
675
+470
| +229% | +$869 | ﹤0.01% | 4061 |
|
|
2024
Q3 | $469 | Hold |
205
| – | – | ﹤0.01% | 4123 |
|
|
2024
Q2 | $397 | Hold |
205
| – | – | ﹤0.01% | 4297 |
|
|
2024
Q1 | $590 | Hold |
205
| – | – | ﹤0.01% | 4181 |
|
|
2023
Q4 | $574 | Hold |
205
| – | – | ﹤0.01% | 4196 |
|
|
2023
Q3 | $518 | Hold |
205
| – | – | ﹤0.01% | 4230 |
|
|
2023
Q2 | $643 | Buy |
+205
| New | +$643 | ﹤0.01% | 4312 |
|